These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 26551696)
1. The 18-kDa mitochondrial translocator protein in gliomas: from the bench to bedside. Janczar K; Su Z; Raccagni I; Anfosso A; Kelly C; Durrenberger PF; Gerhard A; Roncaroli F Biochem Soc Trans; 2015 Aug; 43(4):579-85. PubMed ID: 26551696 [TBL] [Abstract][Full Text] [Related]
2. TSPO as a target for glioblastoma therapeutics. Werry EL; Barron ML; Kassiou M Biochem Soc Trans; 2015 Aug; 43(4):531-6. PubMed ID: 26551689 [TBL] [Abstract][Full Text] [Related]
3. Preclinical TSPO Ligand PET to Visualize Human Glioma Xenotransplants: A Preliminary Study. Buck JR; McKinley ET; Fu A; Abel TW; Thompson RC; Chambless L; Watchmaker JM; Harty JP; Cooper MK; Manning HC PLoS One; 2015; 10(10):e0141659. PubMed ID: 26517124 [TBL] [Abstract][Full Text] [Related]
4. TSPO-PET and diffusion-weighted MRI for imaging a mouse model of infiltrative human glioma. Pigeon H; Pérès EA; Truillet C; Jego B; Boumezbeur F; Caillé F; Zinnhardt B; Jacobs AH; Le Bihan D; Winkeler A Neuro Oncol; 2019 Jun; 21(6):755-764. PubMed ID: 30721979 [TBL] [Abstract][Full Text] [Related]
5. The 18-kDa mitochondrial translocator protein in human gliomas: an 11C-(R)PK11195 PET imaging and neuropathology study. Su Z; Roncaroli F; Durrenberger PF; Coope DJ; Karabatsou K; Hinz R; Thompson G; Turkheimer FE; Janczar K; Du Plessis D; Brodbelt A; Jackson A; Gerhard A; Herholz K J Nucl Med; 2015 Apr; 56(4):512-7. PubMed ID: 25722450 [TBL] [Abstract][Full Text] [Related]
6. TLN-4601 peripheral benzodiazepine receptor (PBR/TSPO) binding properties do not mediate apoptosis but confer tumor-specific accumulation. Bertomeu T; Zvereff V; Ibrahim A; Zehntner SP; Aliaga A; Rosa-Neto P; Bedell BJ; Falardeau P; Gourdeau H Biochem Pharmacol; 2010 Nov; 80(10):1572-9. PubMed ID: 20655882 [TBL] [Abstract][Full Text] [Related]
8. The translocator protein radioligand 18F-DPA-714 monitors antitumor effect of erufosine in a rat 9L intracranial glioma model. Awde AR; Boisgard R; Thézé B; Dubois A; Zheng J; Dollé F; Jacobs AH; Tavitian B; Winkeler A J Nucl Med; 2013 Dec; 54(12):2125-31. PubMed ID: 24212976 [TBL] [Abstract][Full Text] [Related]
9. PK 11195 differentially affects cell survival in human wild-type and 18 kDa translocator protein-silenced ADF astrocytoma cells. Chelli B; Salvetti A; Da Pozzo E; Rechichi M; Spinetti F; Rossi L; Costa B; Lena A; Rainaldi G; Scatena F; Vanacore R; Gremigni V; Martini C J Cell Biochem; 2008 Oct; 105(3):712-23. PubMed ID: 18668527 [TBL] [Abstract][Full Text] [Related]
10. Combined PET Imaging of the Inflammatory Tumor Microenvironment Identifies Margins of Unique Radiotracer Uptake. Zinnhardt B; Pigeon H; Thézé B; Viel T; Wachsmuth L; Fricke IB; Schelhaas S; Honold L; Schwegmann K; Wagner S; Faust A; Faber C; Kuhlmann MT; Hermann S; Schäfers M; Winkeler A; Jacobs AH Cancer Res; 2017 Apr; 77(8):1831-1841. PubMed ID: 28137769 [TBL] [Abstract][Full Text] [Related]
11. Targeting the 18-kDa translocator protein: recent perspectives for neuroprotection. Da Pozzo E; Giacomelli C; Barresi E; Costa B; Taliani S; Passetti Fda S; Martini C Biochem Soc Trans; 2015 Aug; 43(4):559-65. PubMed ID: 26551693 [TBL] [Abstract][Full Text] [Related]
12. Imaging of the glioma microenvironment by TSPO PET. Zinnhardt B; Roncaroli F; Foray C; Agushi E; Osrah B; Hugon G; Jacobs AH; Winkeler A Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):174-185. PubMed ID: 33721063 [TBL] [Abstract][Full Text] [Related]
13. Mapping of Translocator Protein (18 kDa) in Peripheral Sterile Inflammatory Disease and Cancer through PET Imaging. Adhikari A; Singh P; Mahar KS; Adhikari M; Adhikari B; Zhang MR; Tiwari AK Mol Pharm; 2021 Apr; 18(4):1507-1529. PubMed ID: 33645995 [TBL] [Abstract][Full Text] [Related]
14. TSPO PET for glioma imaging using the novel ligand Albert NL; Unterrainer M; Fleischmann DF; Lindner S; Vettermann F; Brunegraf A; Vomacka L; Brendel M; Wenter V; Wetzel C; Rupprecht R; Tonn JC; Belka C; Bartenstein P; Niyazi M Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2230-2238. PubMed ID: 28821920 [TBL] [Abstract][Full Text] [Related]
15. TSPO over-expression increases motility, transmigration and proliferation properties of C6 rat glioma cells. Rechichi M; Salvetti A; Chelli B; Costa B; Da Pozzo E; Spinetti F; Lena A; Evangelista M; Rainaldi G; Martini C; Gremigni V; Rossi L Biochim Biophys Acta; 2008 Feb; 1782(2):118-25. PubMed ID: 18190798 [TBL] [Abstract][Full Text] [Related]
16. Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases. Dupont AC; Largeau B; Santiago Ribeiro MJ; Guilloteau D; Tronel C; Arlicot N Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28387722 [TBL] [Abstract][Full Text] [Related]
17. Delivery of Proapoptotic Agents in Glioma Cell Lines by TSPO Ligand-Dextran Nanogels. Lopalco A; Cutrignelli A; Denora N; Perrone M; Iacobazzi RM; Fanizza E; Lopedota A; Depalo N; de Candia M; Franco M; Laquintana V Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29641449 [TBL] [Abstract][Full Text] [Related]
19. [¹¹C]-(R)PK11195 tracer kinetics in the brain of glioma patients and a comparison of two referencing approaches. Su Z; Herholz K; Gerhard A; Roncaroli F; Du Plessis D; Jackson A; Turkheimer F; Hinz R Eur J Nucl Med Mol Imaging; 2013 Sep; 40(9):1406-19. PubMed ID: 23715902 [TBL] [Abstract][Full Text] [Related]
20. Paeoniflorin elicits the anti-proliferative effects on glioma cell via targeting translocator protein 18 KDa. Gao ZW; Huang YY; Zhang JQ; Rong JY; Qiao GY; Chen N; Yu GD; Luo M; Liu XF J Pharmacol Sci; 2021 Jan; 145(1):115-121. PubMed ID: 33357769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]